Copy number alterations in urothelial carcinomas: Their clinicopathological significance and correlation with DNA methylation alterations

Naotaka Nishiyama, Eri Arai, Ryo Nagashio, Hiroyuki Fujimoto, Fumie Hosoda, Tatsuhiro Shibata, Taiji Tsukamoto, Sana Yokoi, Issei Imoto, Johji Inazawa, Yae Kanai

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The aim of this study was to clarify the genetic backgrounds underlying the clinicopathological characteristics of urothelial carcinomas (UCs). Array comparative genomic hybridization analysis using a 244K oligonucleotide array was performed on 49 samples of UC tissue. Losses of 2q33.3-q37.3, 4p15.2-q13.1 and 5q13.3-q35.3 and gains of 7p11.2-q11.23 and 20q13.12-q13.2 were correlated with higher histological grade, and gain of 7p21.2-p21.12 was correlated with deeper invasion. Losses of 6q14.1-q27 and 17p13.3-q11.1 and gains of 19q13.12-q13.2 and 20q13.12-q13.33 were correlated with lymph vessel involvement. Loss of 16p12.2-p12.1 and gain of 3q26.32-q29 were correlated with vascular involvement. Losses of 5q14.1-q23.1, 6q14.1-q27, 8p22-p21.3, 11q13.5-q14.1 and 15q11.2-q22.2 and gains of 7p11.2-q11.22 and 19q13.12-q13.2 were correlated with the development of aggressive non-papillary UCs. Losses of 1p32.2-p31.3, 10q11.23-q21.1 and 15q21.3 were correlated with tumor recurrence. Unsupervised hierarchical clustering analysis based on copy number alterations clustered UCs into three subclasses: copy number alterations associated with genome-wide DNA hypomethylation, regional DNA hypermethylation on C-type CpG islands and genome-wide DNA hypo- and hypermethylation were accumulated in clusters A, B1 and B2, respectively. Tumor-related genes that may encode therapeutic targets and/or indicators useful for the diagnosis and prognostication of UCs should be explored in the above regions. Both genetic and epigenetic events appear to accumulate during urothelial carcinogenesis, reflecting the clinicopathological diversity of UCs.

Original languageEnglish
Pages (from-to)462-469
Number of pages8
JournalCarcinogenesis
Volume32
Issue number4
DOIs
Publication statusPublished - 2011 Apr
Externally publishedYes

Fingerprint

DNA Methylation
Carcinoma
DNA
Genome
CpG Islands
Comparative Genomic Hybridization
Lymph
Oligonucleotide Array Sequence Analysis
Epigenomics
Blood Vessels
Cluster Analysis
Neoplasms
Carcinogenesis
Recurrence
Genes

ASJC Scopus subject areas

  • Cancer Research

Cite this

Copy number alterations in urothelial carcinomas : Their clinicopathological significance and correlation with DNA methylation alterations. / Nishiyama, Naotaka; Arai, Eri; Nagashio, Ryo; Fujimoto, Hiroyuki; Hosoda, Fumie; Shibata, Tatsuhiro; Tsukamoto, Taiji; Yokoi, Sana; Imoto, Issei; Inazawa, Johji; Kanai, Yae.

In: Carcinogenesis, Vol. 32, No. 4, 04.2011, p. 462-469.

Research output: Contribution to journalArticle

Nishiyama, N, Arai, E, Nagashio, R, Fujimoto, H, Hosoda, F, Shibata, T, Tsukamoto, T, Yokoi, S, Imoto, I, Inazawa, J & Kanai, Y 2011, 'Copy number alterations in urothelial carcinomas: Their clinicopathological significance and correlation with DNA methylation alterations', Carcinogenesis, vol. 32, no. 4, pp. 462-469. https://doi.org/10.1093/carcin/bgq274
Nishiyama, Naotaka ; Arai, Eri ; Nagashio, Ryo ; Fujimoto, Hiroyuki ; Hosoda, Fumie ; Shibata, Tatsuhiro ; Tsukamoto, Taiji ; Yokoi, Sana ; Imoto, Issei ; Inazawa, Johji ; Kanai, Yae. / Copy number alterations in urothelial carcinomas : Their clinicopathological significance and correlation with DNA methylation alterations. In: Carcinogenesis. 2011 ; Vol. 32, No. 4. pp. 462-469.
@article{677bd791bc504ffe9ca03752b4f50ff6,
title = "Copy number alterations in urothelial carcinomas: Their clinicopathological significance and correlation with DNA methylation alterations",
abstract = "The aim of this study was to clarify the genetic backgrounds underlying the clinicopathological characteristics of urothelial carcinomas (UCs). Array comparative genomic hybridization analysis using a 244K oligonucleotide array was performed on 49 samples of UC tissue. Losses of 2q33.3-q37.3, 4p15.2-q13.1 and 5q13.3-q35.3 and gains of 7p11.2-q11.23 and 20q13.12-q13.2 were correlated with higher histological grade, and gain of 7p21.2-p21.12 was correlated with deeper invasion. Losses of 6q14.1-q27 and 17p13.3-q11.1 and gains of 19q13.12-q13.2 and 20q13.12-q13.33 were correlated with lymph vessel involvement. Loss of 16p12.2-p12.1 and gain of 3q26.32-q29 were correlated with vascular involvement. Losses of 5q14.1-q23.1, 6q14.1-q27, 8p22-p21.3, 11q13.5-q14.1 and 15q11.2-q22.2 and gains of 7p11.2-q11.22 and 19q13.12-q13.2 were correlated with the development of aggressive non-papillary UCs. Losses of 1p32.2-p31.3, 10q11.23-q21.1 and 15q21.3 were correlated with tumor recurrence. Unsupervised hierarchical clustering analysis based on copy number alterations clustered UCs into three subclasses: copy number alterations associated with genome-wide DNA hypomethylation, regional DNA hypermethylation on C-type CpG islands and genome-wide DNA hypo- and hypermethylation were accumulated in clusters A, B1 and B2, respectively. Tumor-related genes that may encode therapeutic targets and/or indicators useful for the diagnosis and prognostication of UCs should be explored in the above regions. Both genetic and epigenetic events appear to accumulate during urothelial carcinogenesis, reflecting the clinicopathological diversity of UCs.",
author = "Naotaka Nishiyama and Eri Arai and Ryo Nagashio and Hiroyuki Fujimoto and Fumie Hosoda and Tatsuhiro Shibata and Taiji Tsukamoto and Sana Yokoi and Issei Imoto and Johji Inazawa and Yae Kanai",
year = "2011",
month = "4",
doi = "10.1093/carcin/bgq274",
language = "English",
volume = "32",
pages = "462--469",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Copy number alterations in urothelial carcinomas

T2 - Their clinicopathological significance and correlation with DNA methylation alterations

AU - Nishiyama, Naotaka

AU - Arai, Eri

AU - Nagashio, Ryo

AU - Fujimoto, Hiroyuki

AU - Hosoda, Fumie

AU - Shibata, Tatsuhiro

AU - Tsukamoto, Taiji

AU - Yokoi, Sana

AU - Imoto, Issei

AU - Inazawa, Johji

AU - Kanai, Yae

PY - 2011/4

Y1 - 2011/4

N2 - The aim of this study was to clarify the genetic backgrounds underlying the clinicopathological characteristics of urothelial carcinomas (UCs). Array comparative genomic hybridization analysis using a 244K oligonucleotide array was performed on 49 samples of UC tissue. Losses of 2q33.3-q37.3, 4p15.2-q13.1 and 5q13.3-q35.3 and gains of 7p11.2-q11.23 and 20q13.12-q13.2 were correlated with higher histological grade, and gain of 7p21.2-p21.12 was correlated with deeper invasion. Losses of 6q14.1-q27 and 17p13.3-q11.1 and gains of 19q13.12-q13.2 and 20q13.12-q13.33 were correlated with lymph vessel involvement. Loss of 16p12.2-p12.1 and gain of 3q26.32-q29 were correlated with vascular involvement. Losses of 5q14.1-q23.1, 6q14.1-q27, 8p22-p21.3, 11q13.5-q14.1 and 15q11.2-q22.2 and gains of 7p11.2-q11.22 and 19q13.12-q13.2 were correlated with the development of aggressive non-papillary UCs. Losses of 1p32.2-p31.3, 10q11.23-q21.1 and 15q21.3 were correlated with tumor recurrence. Unsupervised hierarchical clustering analysis based on copy number alterations clustered UCs into three subclasses: copy number alterations associated with genome-wide DNA hypomethylation, regional DNA hypermethylation on C-type CpG islands and genome-wide DNA hypo- and hypermethylation were accumulated in clusters A, B1 and B2, respectively. Tumor-related genes that may encode therapeutic targets and/or indicators useful for the diagnosis and prognostication of UCs should be explored in the above regions. Both genetic and epigenetic events appear to accumulate during urothelial carcinogenesis, reflecting the clinicopathological diversity of UCs.

AB - The aim of this study was to clarify the genetic backgrounds underlying the clinicopathological characteristics of urothelial carcinomas (UCs). Array comparative genomic hybridization analysis using a 244K oligonucleotide array was performed on 49 samples of UC tissue. Losses of 2q33.3-q37.3, 4p15.2-q13.1 and 5q13.3-q35.3 and gains of 7p11.2-q11.23 and 20q13.12-q13.2 were correlated with higher histological grade, and gain of 7p21.2-p21.12 was correlated with deeper invasion. Losses of 6q14.1-q27 and 17p13.3-q11.1 and gains of 19q13.12-q13.2 and 20q13.12-q13.33 were correlated with lymph vessel involvement. Loss of 16p12.2-p12.1 and gain of 3q26.32-q29 were correlated with vascular involvement. Losses of 5q14.1-q23.1, 6q14.1-q27, 8p22-p21.3, 11q13.5-q14.1 and 15q11.2-q22.2 and gains of 7p11.2-q11.22 and 19q13.12-q13.2 were correlated with the development of aggressive non-papillary UCs. Losses of 1p32.2-p31.3, 10q11.23-q21.1 and 15q21.3 were correlated with tumor recurrence. Unsupervised hierarchical clustering analysis based on copy number alterations clustered UCs into three subclasses: copy number alterations associated with genome-wide DNA hypomethylation, regional DNA hypermethylation on C-type CpG islands and genome-wide DNA hypo- and hypermethylation were accumulated in clusters A, B1 and B2, respectively. Tumor-related genes that may encode therapeutic targets and/or indicators useful for the diagnosis and prognostication of UCs should be explored in the above regions. Both genetic and epigenetic events appear to accumulate during urothelial carcinogenesis, reflecting the clinicopathological diversity of UCs.

UR - http://www.scopus.com/inward/record.url?scp=79953708813&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953708813&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgq274

DO - 10.1093/carcin/bgq274

M3 - Article

C2 - 21177765

AN - SCOPUS:79953708813

VL - 32

SP - 462

EP - 469

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 4

ER -